Risultati della ricerca - Ali Hamidi

  • Mostra 1 - 2 risultati su 2
Raffina i risultati
  1. 1
    Copertina

    Practical management of adverse events in patients receiving tarlatamab, a delta‐like ligand 3–targeted bispecific T‐cell engager immunotherapy, for previously treated small cell l... Autoría: Jacob M. Sands, Stéphane Champiat, Horst‐Dieter Hummel, Kelly G. Paulson, Hossein Borghaei, Jean Bustamante Alvarez, David P. Carbone, Jennifer W. Carlisle, Noura J. Choudhury, Jeffrey M. Clarke, Shirish M. Gadgeel, Hiroki Izumi, Alejandro Navarro, Sally C. M. Lau, Philip E. Lammers, Shuang Huang, Ali Hamidi, Sujoy Mukherjee, Taofeek K. Owonikoko

    Pubblicazione 2025
    Fuente: Wiley Open Access
    Tipo de material: Artículo Open Access
    Acceso al recurso
    Enlace del recurso

    Aggiungi alla lista
    Salvato in:
  2. 2
    Copertina

    Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia Autoría: Elias Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, Pilar Martínez‐Sánchez, José J. Rifón Roca, Ryan D. Cassaday, Boris Böll, Anita Rijneveld, Maher Abdul‐Hay, Françoise Huguet, Thomas Cluzeau, Mar Tormo Díaz, Vladan Vucinic, José González‐Campos, Alessandro Rambaldi, Stefan Schwartz, Céline Berthon, Jesús María Hernández‐Rivas, Paul R. Gordon, Monika Brüggemann, Ali Hamidi, Yuqi Chen, Hansen L. Wong, Bharat Panwar, Yuliya Katlinskaya, Ana Markovic, Hagop Kantarjian

    Pubblicazione 2024
    Fuente: Wiley Open Access
    Tipo de material: Artículo Open Access
    Acceso al recurso
    Enlace del recurso

    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: